loader
Please Wait
Applying Filters...

AbbVie Contract Manufacturing AbbVie Contract Manufacturing

X

List of Certificates of Suitability (CEPs) for r0_cep_2022_314___rev_00 Active Pharmaceutical Ingredient (API) issued by the EDQM. Original Data: EDQM Database

Client Virtual Booth
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 Cambrex Profarmaco Milano S.r.l. Paullo IT (1)

filter

01 Rivaroxaban (1)

filter

01 U.S.A (1)

filter

01 Valid (1)

URL Supplier Web Content
R0-CEP 2022-314 - Rev 00
Valid
Chemical
2023-08-04
2932
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for Certificates of Suitability (CEPs) for R0-CEP 2022-314 - Rev 00 of Cambrex Profarmaco Milano S.r.l. Paullo It

Looking for Certificates of Suitability (CEPs) for R0-CEP 2022-314 - Rev 00 of Cambrex Profarmaco Milano S.r.l. Paullo It 1

20

Cambrex Profarmaco Milano S.r.l. Paullo It, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

They are recognized for Cambrex is an innovative life sciences company with a refreshingly human approach.

One of their significant offerings is Rivaroxaban, supported by a 'Valid' Certificate of Suitability (CEP) with the number R0-CEP 2022-314 - Rev 00

This Chemical Type CEP, issued on August 04, 2023, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.

Substance Number 2932 associated with this CEP further emphasizes

Post Enquiry
POST ENQUIRY